It is shown that PTC location critically determines not only NMD efficiency and its variability across cells, but also the spectrum of resulting protein products, including truncated proteins arising from premature termination, full-length proteins generated through translational readthrough, and N-terminally truncated isoforms produced by downstream reinitiation.
Abstract
Nonsense-mediated mRNA decay (NMD) is a translation-dependent mRNA decay pathway triggered by premature termination codons (PTCs). Although NMD is known to eliminate aberrant transcripts, how PTC position influences cell-to-cell heterogeneity in NMD and the resulting protein outputs remains unclear. Here, we used a single-cell NMD analysis system that quantifies cellular variability based on the GFP/mCherry fluorescence ratio. By combining this system with fluorescence-activated cell sorting (FACS), we show that PTC location critically determines not only NMD efficiency and its variability across cells, but also the spectrum of resulting protein products. These include truncated proteins arising from premature termination, full-length proteins generated through translational readthrough, and N-terminally truncated isoforms produced by downstream reinitiation. Our findings reveal that positional and cellular heterogeneity in NMD contribute to proteomic diversity and may underlie the variable phenotypic severity of genetic diseases caused by PTCs. This work establishes a framework for dissecting NMD regulation and its translational consequences. Highlights Protein-level readouts reflect mechanisms underlying NMD escape
Nonsense-mediated decay (NMD) is a vital RNA surveillance mechanism in eukaryotic cells that ensures mRNA quality and regulates gene expression. NMD targets mRNAs with premature translation-termination codons to prevent the production of potentially harmful truncated proteins. But NMD is also involved in modulating the...
Rafaela Lacerda, Miguel Carvalho, L. Romão· Journal of Molecular Biology· 1 citation
Overall, the findings suggest that TA is not a universal response to loss-of-function mutations in yeast, and the ability to resist specific transcriptomic ruptures would thus rely mostly on the general robustness of genetic networks.
Marzena Marszałek, W. Babik, R. Korona et al.· Molecular biology and evolut...· 0 citations
A robust metric derived from splicing quantification in the RNA-seq data to measure NMD efficiency at a sample level is developed and a striking divergence of NMD efficiency in cancers is observed, suggesting that tumors partially erase the NMD signature of their tissue of origin.
L. Zavileyskiy, A. Mironov, D. D. Pervouchine· Acta Naturae· 0 citations
Targeting NMD has the potential to open new avenues for precision cancer therapy by revealing the previously unrealized immunogenic potential of tumors and bridging the gap between RNA biology and cancer immunotherapy.
Sanjoy Majumder, G. K. Panigrahi, Annapurna Sahoo· Molecular Biology Reports· 0 citations
How dysfunction in NMD pathway components—specifically core degradation factors, the exon junction complex, and neuron-specific splicing regulators—underpins an extensive array of neurodevelopmental disorders (NDDs) is examined.
Polina E. Anisimova, A. Filat'eva, Victor S. Tarabykin et al.· Frontiers in Molecular Biosc...· 0 citations
A ribosome tagging and purification strategy is developed that bypasses the prolonged turnover of ribosomal proteins, enabling ribosome profiling with one-hour temporal resolution after neural stimulation, and uncovered previously unknown activity-dependent alternative translation with functional implication, such as t...
Nayan Suryawanshi, Hitoshi Uchida, R. Endo et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.